Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Mitoxantrone Treatment Report
What is Mitoxantrone?

Mitoxantrone is a cancer drug also used in secondary progressive MS to slow progression and to extend the time between relapses in relapsing-remitting MS and progressive relapsing MS. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my MS progress 125 20
Other 11 1
Support another treatment 2 0
Multiple Sclerosis (MS) 2 2
Mobility 2 1
disease-related symptoms 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
5 21%
Moderate
9 38%
Mild
5 21%
None
5 21%

Most commonly reported side effects

tiredness
14 58%
sick to my stomach for a day or two
11 46%
slight temporary hair loss
9 38%
Headaches
8 33%
Aches and pains
7 29%
Weakness one day a week after
4 17%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Mitoxantrone. See all 21 dosages ►

  1 as needed 1g as needed 25 2mg/mL as needed 2 mg as needed 2mg/mL as needed 3other as needed 7 2mg/mL as needed 1 1 hr 8 mg yearly 1 mg monthly 1 monthly 2 mg monthly 10 5 mL monthly 20 11 mg monthly 20 mg monthly 2 mg daily 2 mg one time 200 mg
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Mitoxantrone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
40 40% Course of treatment ended: 40%
Doctor's advice
25 25% Doctor's advice: 25%
Did not seem to work
25 25% Did not seem to work: 25%
Side effects too severe
25 25% Side effects too severe: 25%
Other
12 12% Other: 12%
Personal research
4 4% Personal research: 4%
Not indicated
1 1% Not indicated: 1%

See all 97 patients who’ve stopped taking Mitoxantrone

Duration See details about how long patients take this treatment ▼

Currently Taking Mitoxantrone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
2
4
5
12

Stopped Taking Mitoxantrone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
6
16
22
24
19

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
21 88%
Usually
1 4%
Sometimes
0 0%
Never
2 8%

Burden

Difficulty being on treatment

Very
3 13%
Somewhat
8 33%
A little
3 13%
Not at all
10 42%

Cost

Paid out of pocket

$200+
2 8%
$100-199
1 4%
$50-99
0 0%
$25-49
0 0%
< $25
9 38%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.